Neuronascent, Inc.

Clarksville, MD

UEI
CT5HTN1BU9B1
CAGE
3W4C5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
6030 Daybreak Cir, Clarksville, MD 21029, USA
Website
neuronascent.com
Founded
2004
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Completion of non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy… U01AG082687 National Institute on Aging (NIH) $10,837,112
Neuron regenerative therapeutic, NNI-362, for first-in-human safety and PK for ad R01AG056561 National Institute on Aging (NIH) $3,271,220

Quick answers

Is Neuronascent, Inc. registered in SAM.gov?

Yes. Neuronascent, Inc.'s SAM.gov registration is active through February 5, 2027.

What is Neuronascent, Inc.'s most recent federal award?

Neuronascent, Inc.'s most recent federal grant award is Completion of non-clinical long-term GLP safety and GMP manufacture for first-in-class neuron regenerative therapy… (U01AG082687), from National Institute on Aging (NIH), on September 1, 2023.

On GovTribe

See Neuronascent, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login